KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹310 Cr | ₹237 Cr | ₹218 Cr | ₹208 Cr | ₹202 Cr |
What is the latest Total Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹310 Cr |
| Mar2024 | ₹237 Cr |
| Mar2023 | ₹218 Cr |
| Mar2022 | ₹208 Cr |
| Mar2021 | ₹202 Cr |
How is Total Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹310 Cr | 30.49 | |
| Mar2024 | ₹237 Cr | 9.17 | |
| Mar2023 | ₹218 Cr | 4.42 | |
| Mar2022 | ₹208 Cr | 3.19 | |
| Mar2021 | ₹202 Cr | - | |
Compare Total Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹652.2 Cr | -1.8% | 2.7% | -15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -1.8% |
2.7% |
-15.9% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses